This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Echocardiographic Features of Cardiac Echinococcal Infection.
CASE (Philadelphia, Pa.) · 2021 · first author
Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence
BMJ Open · 2018 · first author
Latest funding
- $100,000
The SWAGAT Study: Smoking cessation and Weight gain Attenuation with dual Glucagon like Peptide Receptor & Gastric Inhibitory Receptor Agonist- Tirzepatide: A double blinded RCT.
CIHR · 2026 · Principal investigator
2 publications.
Echocardiographic Features of Cardiac Echinococcal Infection.
Mir H, McClure A, Thampinathan B, Chow C, Cusimano RJ, Bogoch II, Thavendiranathan P
Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence
Mir H, Siemieniuk RAC, Ge LC, Foroutan F, Fralick M, Syed T, Lopes LC, Kuijpers T, Mas J-L, Vandvik PO
The SWAGAT Study: Smoking cessation and Weight gain Attenuation with dual Glucagon like Peptide Receptor & Gastric Inhibitory Receptor Agonist- Tirzepatide: A double blinded RCT.
Principal investigators: Selby, Peter L; Agarwal, Sri Mahavir; Melamed, Osnat; Mir, Hassan; Patton, Ian T; Tang, Victor M; Veldhuizen, Scott R; Zawertailo, Laurie A
Keywords: Addiction; Cardiometabolic Risk; Gastric Inhibitory Peptide; Glucagon-Like Peptide-1 Receptor Agonist; Nicotine Dependence; Obesity; Overweight; Smoking Cessation; Tobacco Use Disorder; Trizepatide
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Thomas Agoritsas and Gordon Guyatt: 138 shared papers
- Farid Foroutan and Gordon Guyatt: 49 shared papers
- Thomas Agoritsas and Farid Foroutan: 11 shared papers
- Gordon Guyatt and Hassan Mir: 2 shared papers
- Thomas Agoritsas and Michael Fralick: 1 shared paper
- Thomas Agoritsas and Hassan Mir: 1 shared paper
- Farid Foroutan and Paaladinesh Thavendiranathan: 1 shared paper
- Farid Foroutan and Michael Fralick: 1 shared paper
- Farid Foroutan and Hassan Mir: 1 shared paper
- Gordon Guyatt and Michael Fralick: 1 shared paper
- Gordon Guyatt and Hassan Mir: 1 shared paper
- Paaladinesh Thavendiranathan and Hassan Mir: 1 shared paper
- Paaladinesh Thavendiranathan and Hassan Mir: 1 shared paper
- Hassan Mir and Hassan Mir: 1 shared paper
- Michael Fralick and Hassan Mir: 1 shared paper
- Health Research Methods, Evidence, and Impact
- Cardiology
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Thomas Agoritsas
Health Research Methods, Evidence, and Impact
1 shared papers, latest 2018
Farid Foroutan
Health Research Methods, Evidence, and Impact
1 shared papers, latest 2018
Gordon Guyatt
Health Research Methods, Evidence, and Impact
1 shared papers, latest 2018
Paaladinesh Thavendiranathan
Cardiology
1 shared papers, latest 2021
Hassan Mir
Faculty
1 shared papers, latest 2021
Michael Fralick
Faculty
1 shared papers, latest 2018
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.